College faculty to oversee $14 million study evaluating optimal aspirin doses in pregnancy

A research team led by faculty at The Ohio State University College of Medicine has been approved for a $14 million award to study whether a higher daily dose of aspirin is more effective in decreasing the risk of dangerous blood pressure complications among some pregnant people.

Maged Costantine, MD, professor of Obstetrics and Gynecology, and Kara Rood, MD, associate professor of Obstetrics and Gynecology at the Ohio State College of Medicine, are co-principal investigators of the study.

With the $14 million award from the Patient-Centered Outcomes Research Institute, the research team aims to enroll more than 10,000 pregnant people at higher risk for hypertensive disorders across the United States to better understand the ideal dose of aspirin to prevent blood pressure problems in pregnancy.